Open AccessNew Clinical Trials With Evolocumab and Alirocumab on Cardiovascular Outcomes, in Patients With High Rsk of Acute Coronary Syndromes
Author(s) -
Singh Rb,
Ján Fedačko,
Galal Elkilany,
Narsingh Verma,
Narsingh Verma
Publication year - 2015
Publication title -
journal of cardiology and therapy
Language(s) - English
Resource type - Journals
eISSN - 2312-122X
pISSN - 2309-6861
DOI - 10.17554/j.issn.2309-6861.2015.02.93
Subject(s) - alirocumab , evolocumab , medicine , pcsk9 , kexin , proprotein convertase , clinical trial , monoclonal , adverse effect , acute coronary syndrome , subtilisin , cardiology , monoclonal antibody , cholesterol , antibody , lipoprotein , immunology , myocardial infarction , ldl receptor , chemistry , apolipoprotein a1 , enzyme , biochemistry